Coronary Artery Bypass Graft Devices – Market Insights – United States

The US CABG device market will grow modestly, driven by increasing complex CAD cases and the adoption of surgical technologies. Favorable clinical evidence, particularly in favor of CABG over PCI, will propel the market forward. Adoption of OPCAB devices and anastomosis assist devices due to rising interest in off-pump approaches will drive the overall market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for CABG devices in the US, with market projections from 2019 through 2033.

The increasing prevalence of complex CAD cases will drive demand for innovative devices and result in a higher proportion of complex PCIs that will drive the market growth.

How does procedure preference differ by treatment complexity in the US?

What are the key preferences of physicians when selecting CABG devices?

In the last two decades, continued technological improvement has led to the development of minimally invasive approaches to CABG surgery, such as MIDCAB, MICS CABG surgery, and TECAB.

What is the current level of clinical support for MIDCAB, MICS CABG and TECAB surgery?

What is the growth prospect for MIDCAB procedures?

Price competition will limit revenue growth potential, especially in light of increased cost-consciousness among healthcare facilities.

Which segments will experience the most price competition?

In which segments and to what extent will adoption of premium-priced next-generation products offset the effects of price competition?

What strategies can CABG device manufacturers adapt to address the increasing cost-consciousness among healthcare facilities?